Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma

dc.contributor.author	Onuk, Ozkan
dc.contributor.author	Nuhoglu, Baris
dc.contributor.author	Ozkan, Arif
dc.contributor.author	Tas, Tuncay
dc.contributor.author	Cilesiz, Nusret Can
dc.contributor.author	Hazar, Aydin Ismet
dc.contributor.author	Balci, Mustafa Bahadir Can
dc.date.accessioned	2021-12-21T08:46:00Z
dc.date.available	2021-12-21T08:46:00Z
dc.date.issued	2019
dc.identifier.issn	2146-6505
dc.identifier.issn	2147-1894
dc.identifier.uri	https://doi.org/10.5152/jarem.2019.2300
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1860
dc.description.abstract	Objective: The aim of the present study was to evaluate caveolin-1 (CAV-1) levels as a possible alternative for the prostate specific antigen in the diagnosis of patients with prostate adenocarcinoma (PCa). Methods: The study was conducted with 33 cases (
dc.language.iso	English
dc.publisher	Aves
dc.rights	Bronze
dc.title	Comparison of Caveolin-1 and PSA in Prostate Adenocarcinoma
dc.type	Article
dc.relation.journal	Journal Of Academıc Research In Medıcıne-Jarem
dc.identifier.issue	3
dc.identifier.startpage	121
dc.identifier.endpage	124
dc.identifier.volume	9
dc.identifier.doi	10.5152/jarem.2019.2300
dc.relation.issue	3
dc.relation.volume	9

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.